First Commonwealth Financial Corp’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
First Commonwealth Financial Corp's VRTX Position: Q1 2026 in Review
First Commonwealth Financial Corp increased its Vertex Pharmaceuticals (VRTX) stake by 0.09% in Q1 2026, buying an estimated $466 and bringing the position to 1,135 shares worth $507K. The position accounts for 0.08% of the portfolio, ranked #178.
First Commonwealth Financial Corp first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. The position peaked at $583K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- First Commonwealth Financial Corp held 1,135 shares of Vertex Pharmaceuticals worth $507K as of Q1 2026.
- First Commonwealth Financial Corp bought 1 Vertex Pharmaceuticals share in Q1 2026, an estimated $466.
- Vertex Pharmaceuticals made up 0.08% of First Commonwealth Financial Corp's portfolio in Q1 2026, its #178 holding.
- First Commonwealth Financial Corp first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
- First Commonwealth Financial Corp's Vertex Pharmaceuticals position peaked at $583K in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on First Commonwealth Financial Corp's 13F filing for Q1 2026, filed 14 May 2026.